JMP Securities analyst Patrick Walravens maintained a Buy rating on Braze (BRZE – Research Report) today and set a price target of $68.00. The ...

JMP Securities analyst Andrew Boone maintained a Buy rating on Snap (SNAP – Research Report) today and set a price target of $14.00. The ...

A leaker is out with a new set of iPhone 17 dummy models based on CAD drawings, and these latest ones have a detail not previously seen. The mockups of the two iPhone 17 Pro models appear to ...

On social media today, Apple leaker Majin Bu shared an image comparing the thickness of the iPhone 17 Air to the iPhone 17 Pro. In this photo, iPhone 17 Air looks wildly thin. Of course ...

The iPhone 16 line has only recently landed at the time of writing, and yet there are already numerous iPhone 17 claimed leaks – some of which emerged even before the launch of Apple’s latest ...

Investing.com — 周一，Citizens JMP重申了对Acrivon Therapeutics Inc (NASDAQ:ACRV)的"市场表现优于大盘"评级，目标价维持在17.00美元。根据InvestingPro数据，这一目标价较当前5.36美元的价格有显著上涨空间，分析师目标价区间为17美元至30美元。此次评级重申主要关注Acrivon即将 ...

Bong Joon-ho follows up his Oscar win for Parasite with Mickey 17, the right movie for our current political moment: A bleakly hilarious sci-fi comedy starring multiple Robert Pattinsons as the ...

The best logo maker is an essential design tool for anyone looking to differentiate their brand online. My round-up here offers apps ideal for designers and non-designers who need to help their ...

A top Apple exec says the 2025 iPhone launch will be its 'most ambitious' to date. With 15+ years of covering the iPhone under our belts, here's what seems most likely for the iPhone 17.

18 analyst firms have reported ratings in the last year. The last upgrade for Larimar Therapeutics Inc happened on November 17, 2023 when Citigroup raised their price target to $4.5. Citigroup ...

Jefferies previously had a hold for Root Inc. The last downgrade for Root Inc happened on November 22, 2024 when JMP Securities changed their price target from N/A to N/A for Root Inc. Analysts ...